>

Case Studies

Filtered by Service Areas
Filtered by Therapeutic Areas
arrow&v
arrow&v

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Therapeutic Area

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Therapeutic Area

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Therapeutic Area

Applied advanced analysis to understand manufacturing variance for cell therapy firm

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Operation Strategy (CMC)

Therapeutic Area

Cell therapy

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Therapeutic Area

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Therapeutic Area

What can portfolio management do for molecule teams?

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Portfolio Management (Molecule Teams)

Therapeutic Area

N/A

What can portfolio management do for early commercialization?

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Portfolio Management (Early Commercialization)

Therapeutic Area

N/A

What can portfolio management do for governance?

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Portfolio Management (Governance)

Therapeutic Area

N/A

Website assessment for early stage biopharmaceutical company

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Market Research (Qualitative)

Therapeutic Area

Central Nervous System (Alzheimer's, Lysosomal Storage Disorders)

Market research for novel cell transplant procedure

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Market Research (Qualitative)

Therapeutic Area

Oncology (ASCT)

Support services optimization for orphan specialty product portfolio

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Market Research

Therapeutic Area

Gene Therapy & Orphan Disease (Orphan)

Demand modeling and scenario planning for a novel, mass-market agent for hypercholesterolemia

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Market Research (Demand Modelling, Scenario Planning)

Therapeutic Area

Other Therapeutic Areas (Cardiovascular)

Positioning for a novel, ultra-orphan specialty drug: KOL and payer deep dive

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Market Research (KOL, Payor, Benchmarking)

Therapeutic Area

Gene Therapy & Orphan Disease (Orphan)

What is the market potential for a novel formulation for treating Diabetic Foot Ulcers?

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Market Research (Market Forecast, TPP Development)

Therapeutic Area

Other Therapeutic Areas (Diabetic Foot Ulcer)

How to forecast R&D costs and allocate resources appropriately for a rare disease company?

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Portfolio Management (Activity-Based Costing)

Therapeutic Area

Gene Therapy & Orphan Drugs (Orphan)

Process overhaul at a Top 5 pharma

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Portfolio Management

Therapeutic Area

N/A

What is the go-to-market strategy in the U.S. for an Asia-based medical device startup company?

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy (Go-to-market Strategy, Valuation, Investment Deck Preparation)

Therapeutic Area

Other Therapeutic Areas (Medical Devices)

Analytical model to understand IP-driven commercial risks to an oncology portfolio

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy (Modeling, Intellectual Property)

Therapeutic Area

Oncology (Immuno-oncology)

Determine the better investment (in-house vs in-license) option for a small molecule drug

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy (Valuation, Business Development)

Therapeutic Area

Central Nervous System (Parkinson's, ALS)

Develop a strategic outlook for an infectious disease (ID) area and define organizational framework

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy (TPP Development, Disease Area Strategy)

Therapeutic Area

Other Therapeutic Areas (Infectious Disease)

Platform technology technical evaluation and deal trends

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy (Technical Assessment)

Therapeutic Area

Other Therapeutic Areas (CAR-T, CRISPR), Gene Therapy

Strategic competitive intelligence assessments

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy (Competitive Insights)

Therapeutic Area

Central Nervous System (Alzheimer's, Parkinson's, ALS)

Immuno-oncology competitive intelligence

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy (Competitive assessment)

Therapeutic Area

Oncology (Solid Tumor, Immuno-oncology)

Technology prioritization for stem cell (iPSC) regenerative medicine technology

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy (Technical Assessment)

Therapeutic Area

Oncology (Stem Cell)

Landscape assessment, development opportunities, and forecasting for novel prostate cancer molecule

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy (Market Forecast, Competitive Assessment)

Therapeutic Area

Oncology (Solid Tumor, Prostate)

Market forecast and technology valuation for a novel immuno-oncology cell therapy

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy (Valuation and Market Forecast)

Therapeutic Area

Oncology (Cell Therapy, Hematology)

Detailed global sales forecast and NPV model in Ulcerative Colitis and Crohn’s Disease

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy (Valuation)

Therapeutic Area

Auto-immune (UC and Crohn's)

Indication prioritization for platform technology

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy (Indication Assessment)

Therapeutic Area

Central Nervous System (Alzheimer's)

How to prioritize indications for an early stage company with a disruptive technology?

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy (Indication Prioritization)

Therapeutic Area

Central Nervous System

Portfolio planning and management

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy (Indication Prioritization)

Therapeutic Area

Gene Therapy & Orphan Disease

Company Strategy Alignment

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy (Corporate Strategy)

Therapeutic Area

Infectious Disease

Indication evaluation and prioritization for development stage pharmaceutical client

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy (Indication Prioritization)

Therapeutic Area

Gene Therapy & Orphan Disease

How to prioritize indications for an early stage company with a disruptive technology?

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy (Indication Prioritization)

Therapeutic Area

Gene Therapy & Orphan Disease

On-demand, Short-term Ops Support for a Pre-IND Biotech

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Operation Strategy (CMC)

Therapeutic Area

Oncology, Other Therapeutic Areas

Assess the biosimilars market and create a medical affairs strategy to prepare for biosimilar launches

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Operation Strategy (medical affairs)

Therapeutic Area

Oncology (immunoncology)

Launch messaging and positioning for a specialty product

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Market Research (launch messaging and positioning)

Therapeutic Area

Gene Therapy & Orphan Disease

Market research for novel oncology drug with NGS vs. IHC diagnostic strategy

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Market Research (Quantitative and Qualitative Study)

Therapeutic Area

Oncology (diagnostics, NGS, Solid Tumor)

US quantitative market assessment: novel therapy for infectious disease

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Market Research (Quantitive & Qualitative Study, TPP testing, Market Forecast Research)

Therapeutic Area

Other Therapeutic Areas (Infectious Disease, Tuberculosis)

Analytics overhaul at a top 10 pharma

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Portfolio Management

Therapeutic Area

N/A

Pre-clinical Stage, Cutting Edge Biotech in Need of Strategy and Analysis Leverage

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy

Therapeutic Area

Central Nervous System

What is the product positioning strategy for two novel early stage IO candidates for global pharma company?

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy, Portfolio Management (Disease Area Strategy)

Therapeutic Area

Oncology (Solid Tumor), Auto-immune

Quantitative market assessment of preselected diseases and selection of potential new indications

fpbullet.png

I'm a paragraph. Click here to add your own text and edit me. It's easy.

See what we did, our results and insights >
Services Area

Commercial Strategy (Indication Prioritization), Portfolio Management

Therapeutic Area

Gene Therapy & Orphan Disease